![Stephan Oehen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Stephan Oehen
Oprichter bij Priothera Ltd.
Actieve functies van Stephan Oehen
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Oehen Pr | Corporate Officer/Principal | - | - |
Priothera SAS
![]() Priothera SAS BiotechnologyHealth Technology Part of Priothera Ltd., Priothera SAS is a French company dedicated to improving the lives of patients suffering from hematological malignancies by delivering an innovative immune modulator to enhance the curative potential of both allogeneic hematopoietic stem cell transplantation (HSCT) and CAR-T cell therapy. The company is based in Saint-Louis, France. Priothera is leading the way in developing Mocravimod, a S1P receptor modulator as an adjunctive and maintenance immune therapy to allo-HSCT and to CAR-T. Mocravimod has the potential to reduce the occurrence of (acute) GVHD without suppressing T cell function, thus GVL is maintained. Priothera is developing Mocravimod (KRP203) to significantly improve the clinical outcome of allo-HSCT and CAR-T therapy. The company was founded in 2020 by Philippe Lievre, Florent Gros, Brice R. Suire, Stephan Oehen, Simone Seiter. Florent Gros has been the CEO since 2020. | Operationeel Directeur | 30-09-2020 | - |
Oprichter | 30-09-2020 | - | |
Priothera Ltd.
![]() Priothera Ltd. BiotechnologyHealth Technology Priothera Ltd. engages in the development of orally delivered sphingosine-1-phosphate (S1P) receptor modulators for hematological malignancies. The company was founded by Florent Gros, Shaval Patel, and Brice Suire in 2020 and is headquartered in Dublin, Ireland. | Operationeel Directeur | 01-01-2020 | - |
Oprichter | 01-01-2020 | - |
Loopbaan van Stephan Oehen
Eerdere bekende functies van Stephan Oehen
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Grayling Schweiz AG | Algemeen Directeur | 01-01-2011 | 01-01-2013 |
Investinswitzerland | Oprichter | - | - |
POWERLAND AG | Directeur/Bestuurslid | 26-03-2014 | - |
Statistieken
Internationaal
Zwitserland | 4 |
Duitsland | 2 |
Frankrijk | 2 |
Operationeel
Founder | 3 |
Chief Operating Officer | 2 |
Director/Board Member | 1 |
Sectoraal
Health Technology | 3 |
Consumer Non-Durables | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 6 |
---|---|
Powerland AG
![]() Powerland AG Consumer SundriesConsumer Non-Durables Powerland AG engages in the design, production, marketing and sale of bags and other textile and leather products. The company was founded in 2003 and is headquartered in Frankfurt, Germany. | Consumer Non-Durables |
Oehen Pr | |
Investinswitzerland | |
Grayling Schweiz AG | |
Priothera SAS
![]() Priothera SAS BiotechnologyHealth Technology Part of Priothera Ltd., Priothera SAS is a French company dedicated to improving the lives of patients suffering from hematological malignancies by delivering an innovative immune modulator to enhance the curative potential of both allogeneic hematopoietic stem cell transplantation (HSCT) and CAR-T cell therapy. The company is based in Saint-Louis, France. Priothera is leading the way in developing Mocravimod, a S1P receptor modulator as an adjunctive and maintenance immune therapy to allo-HSCT and to CAR-T. Mocravimod has the potential to reduce the occurrence of (acute) GVHD without suppressing T cell function, thus GVL is maintained. Priothera is developing Mocravimod (KRP203) to significantly improve the clinical outcome of allo-HSCT and CAR-T therapy. The company was founded in 2020 by Philippe Lievre, Florent Gros, Brice R. Suire, Stephan Oehen, Simone Seiter. Florent Gros has been the CEO since 2020. | Health Technology |
Priothera Ltd.
![]() Priothera Ltd. BiotechnologyHealth Technology Priothera Ltd. engages in the development of orally delivered sphingosine-1-phosphate (S1P) receptor modulators for hematological malignancies. The company was founded by Florent Gros, Shaval Patel, and Brice Suire in 2020 and is headquartered in Dublin, Ireland. | Health Technology |
- Beurs
- Insiders
- Stephan Oehen
- Ervaring